Olanzapine induced hyperprolactinemia
Journal: International Journal of Basic & Clinical Pharmacology (Vol.2, No. 6)Publication Date: 2013-12-01
Authors : Veena Nayak Virupaksha Devaramane Deepak Mallya Panambur V. Bhandary;
Page : 836-837
Keywords : Olanzapine; Atypical antipsychotic; Hyperprolactinemia;
Abstract
Olanzapine, a second generation antipsychotic is widely used for the treatment of schizophrenia and bipolar disorders. Though olanzapine is an efficacious antipsychotic it has been associated with many adverse effects like weight gain, hyperlipidemia, diabetes mellitus, etc necessitating its discontinuation. Here, we present two cases of hyperprolactinemia induced by olanzapine. [Int J Basic Clin Pharmacol 2013; 2(6.000): 836-837]
Other Latest Articles
- Fixed drug eruption due to paracetamol
- Toxic epidermal necrolysis induced by acetaminophen: a case report
- Self medicated Combiflam induced acute dermatological drug reaction
- Analgesic and antipyretic activity of methanolic extract of Leucas Clarki in animal models
- Root cause analysis of medication errors at a multi-specialty hospital in Western India
Last modified: 2013-12-16 02:25:53